Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Mid-range Performer
1312.3000 -2.50 (-0.19%)
NSE Sep 15, 2025 12:50 PM
Volume: 57,997
 

1312.30
-0.19%
Karvy
IPCA Labs total revenues declined by 4% YoY to Rs 7,492 mn (lower than our estimates of Rs 8,265 mn) due to tepid performance of Export formulations and flat growth in Domestic formulations. Its operating margins decreased by 540bps YoY to 11.9% (lower than our estimate of 14.2%) during the quarter due to lower gross margins and higher expenditure.
Number of FII/FPI investors decreased from 294 to 270 in Jun 2025 qtr
More from Ipca Laboratories Ltd.
Recommended